| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
300,672,000 |
| Market
Cap: |
441.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.36 - $14.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 7.8 |
| Insider 6 Months : 7.8 |
| Insider 3/6 Months : 16 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
40,000 |
40,000 |
40,000 |
40,000 |
| Total Buy Value |
$176,160 |
$176,160 |
$176,160 |
$176,160 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
192,570 |
243,582 |
436,886 |
654,669 |
| Total Sell Value |
$1,111,017 |
$1,552,073 |
$3,531,312 |
$5,254,296 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
11 |
13 |
20 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hunkapiller Michael |
Director |
– • – |
2021-02-24 |
4 |
OE |
$5.27 |
$1,613,096 |
D/D |
266,427 |
1,114,832 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-23 |
4 |
AS |
$30.90 |
$13,022,317 |
D/D |
(373,321) |
848,405 |
|
-10% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-23 |
4 |
OE |
$2.63 |
$2,227,849 |
D/D |
373,321 |
1,221,726 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-22 |
4 |
AS |
$37.17 |
$8,967,407 |
D/D |
(229,127) |
848,405 |
|
-8% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-02-22 |
4 |
OE |
$2.63 |
$1,266,251 |
D/D |
229,127 |
1,077,532 |
|
- |
|
| Schaefer Eric |
Chief Accounting Officer |
• – – |
2021-02-22 |
4 |
S |
$39.20 |
$150,606 |
D/D |
(3,842) |
88,474 |
|
8% |
|
| Kim Susan G. |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,300 |
156,300 |
|
- |
|
| Ordonez Kathy |
Director |
– • – |
2021-02-16 |
4 |
S |
$47.58 |
$10,595,810 |
D/D |
(220,771) |
21,875 |
|
27% |
|
| Ordonez Kathy |
Director |
– • – |
2021-02-16 |
4 |
OE |
$2.63 |
$915,243 |
D/D |
185,879 |
242,646 |
|
- |
|
| Schaefer Eric |
Chief Accounting Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,050 |
92,316 |
|
- |
|
| Henry Christian O |
President & CEO |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
765,000 |
|
- |
|
| Ericson William W. |
Director |
– • – |
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
68 |
68 |
|
- |
|
| Ericson William W. |
Director |
– • – |
2021-02-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(750,000) |
4,848,397 |
|
- |
|
| Livingston Randall S |
Director |
– • – |
2021-02-12 |
4 |
S |
$48.07 |
$3,244,455 |
D/D |
(67,500) |
0 |
|
35% |
|
| Livingston Randall S |
Director |
– • – |
2021-02-12 |
4 |
OE |
$1.83 |
$294,400 |
D/D |
67,500 |
67,500 |
|
- |
|
| Botstein David |
Director |
– • – |
2021-02-12 |
4 |
S |
$49.61 |
$7,939,764 |
D/D |
(160,000) |
0 |
|
35% |
|
| Botstein David |
Director |
– • – |
2021-02-12 |
4 |
OE |
$1.93 |
$706,800 |
D/D |
160,000 |
160,000 |
|
- |
|
| Shapiro Lucy |
Director |
– • – |
2021-02-12 |
4 |
S |
$50.40 |
$5,123,966 |
D/D |
(101,666) |
0 |
|
35% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-25 |
4 |
AS |
$35.17 |
$4,556,901 |
D/D |
(125,406) |
848,405 |
|
-27% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-25 |
4 |
OE |
$6.14 |
$769,993 |
D/D |
125,406 |
973,811 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-22 |
4 |
AS |
$35.92 |
$5,547,490 |
D/D |
(150,857) |
848,405 |
|
-32% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-22 |
4 |
OE |
$6.14 |
$926,262 |
D/D |
150,857 |
999,262 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-21 |
4 |
AS |
$35.44 |
$9,457,071 |
D/D |
(258,521) |
848,405 |
|
-26% |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-21 |
4 |
OE |
$2.27 |
$691,411 |
D/D |
208,711 |
1,106,926 |
|
- |
|
| Hunkapiller Michael |
Director |
– • – |
2021-01-20 |
4 |
AS |
$38.79 |
$8,426,269 |
D/D |
(215,026) |
898,215 |
|
-32% |
|
239 Records found
|
|
Page 4 of 10 |
|
|
0.09 (6.52%) 
